SWOT Analysis for Aethlon Medical Inc

Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Stock gained more than 20% in one month
Stock with Low PE (PE < = 10)
RSI indicating price strength

Promoter decreasing their shareholding
Stocks with Quarter Change % less than Industry
Promoter holding decreased by more than -2% QoQ
Negative profit growth, promoters decreasing shareholding QoQ
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Highest fall from 52 Week High
Top Losers
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Book Value Per Share deteriorating for last 2 years
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter